UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genomic Factors and Therapeutic Approaches in HIV-Associated Neurocognitive Disorders: A Comprehensive Review

International journal of molecular sciences, 2023-09, Vol.24 (18), p.14364

2023

Volltextzugriff (PDF)

Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients

International journal of molecular sciences, 2022-09, Vol.23 (17), p.9591

2022

Volltextzugriff (PDF)

Protein Plasma Levels of the IGF Signalling System Are Altered in Major Depressive Disorder

International journal of molecular sciences, 2023-10, Vol.24 (20), p.15254

2023

Volltextzugriff (PDF)

Therapeutic Approaches in Lysosomal Storage Diseases

Biomolecules (Basel, Switzerland), 2021-11, Vol.11 (12), p.1775

2021

Volltextzugriff (PDF)

Inflammatory and Cardiovascular Biomarkers to Monitor Fabry Disease Progression

International journal of molecular sciences, 2024-06, Vol.25 (11), p.6024

2024

Volltextzugriff (PDF)

Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients

Frontiers in pharmacology, 2024-04, Vol.15, p.1384198-1384198

2024

Volltextzugriff (PDF)

Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two‐year follow‐up of the observational, prospective, controlled, and multicenter ERACI IV registry

Catheterization and cardiovascular interventions, 2017-01, Vol.89 (1), p.37-46

2017

Volltextzugriff (PDF)

Trends in primary percutaneous coronary intervention for the treatment of acute coronary ST-elevation myocardial infarction in Latin American countries: insights from the CECI consortium

Frontiers in cardiovascular medicine, 2024-05, Vol.11, p.1275907-1275907

2024

Volltextzugriff (PDF)

Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?

Biomedicines, 2021-07, Vol.9 (8), p.925

2021

Volltextzugriff (PDF)

Transapical Implantation of a 2nd-Generation JenaValve Device in Patient with Extremely High Surgical Risk

Case reports in cardiology, 2015-01, Vol.2015 (2015), p.1-6

2015

Volltextzugriff (PDF)

Association between Peer Victimization (PV) in Childhood/Adolescence and Personality Disorders among Adult Patients

International journal of translational medicine, 2023-01, Vol.3 (1), p.12-26

2023

Volltextzugriff (PDF)

Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): Immediate and long-term results

The American journal of medicine, 2005-07, Vol.118 (7), p.743-751

2005

Volltextzugriff (PDF)

Changes in the safety paradigm with percutaneous coronary interventions in the modern era:Lessons learned from the ASCERT registry

World journal of cardiology, 2012-08, Vol.4 (8), p.242-249

Alfredo E Rodríguez Carlos Fernández-Pereira Alfredo M Rodríguez-Granillo

2012

Volltextzugriff (PDF)

Five-Year Follow-Up of the Argentine Randomized Trial of Coronary Angioplasty With Stenting Versus Coronary Bypass Surgery in Patients With Multiple Vessel Disease (ERACI II)

Journal of the American College of Cardiology, 2005-08, Vol.46 (4), p.582-588

2005

Volltextzugriff (PDF)

Adjudicating Causes of Death in Revascularization Randomized Clinical Trials

JACC. Cardiovascular interventions, 2023-07, Vol.16 (14), p.1820-1820

2023

Volltextzugriff (PDF)

Drug-Eluting vs Bare-Metal Stents for Percutaneous Coronary Intervention

JAMA internal medicine, 2021-07, Vol.181 (7), p.1012

2021

Volltextzugriff (PDF)

Early Assessment of Myocardial Viability by the Use of Delayed Enhancement Computed Tomography After Primary Percutaneous Coronary Intervention

JACC. Cardiovascular imaging, 2009-09, Vol.2 (9), p.1072-1081

2009

Volltextzugriff (PDF)

Increased incidence of serious late adverse events with drug-eluting stents when compared with coronary artery bypass surgery: a cause of concern

Future cardiology, 2020-11, Vol.16 (6), p.711-723

2020

Volltextzugriff (PDF)

TCT-644 Use of New Thienopyridines in Patients with Coronary Artery Disease Treated with Percutaneous Coronary Interventions in Argentina. Results From A “Real World” Multicenter Registry

Journal of the American College of Cardiology, 2018-09, Vol.72 (13), p.B257-B257

2018

Volltextzugriff (PDF)

Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease

Journal of the American College of Cardiology, 2017-01, Vol.69 (1), p.116-117

2017

Volltextzugriff (PDF)

High Non-Cardiac Death Incidence Should Be a Limitation of Drug-Eluting Stents Implantation? Insights from Recent Randomized Data

Diagnostics (Basel), 2023-04, Vol.13 (7), p.1321

2023

Volltextzugriff (PDF)

Pilot study of oral rapamycin to prevent restenosis in patients undergoing coronary stent therapy: Argentina Single-Center Study (ORAR Trial)

The Journal of invasive cardiology, 2003-10, Vol.15 (10), p.581-584

2003

Volltextzugriff (PDF)

Coronary Stent Thrombosis in the Current Drug-Eluting Stent Era: Insights From the ERACI III Trial

Journal of the American College of Cardiology, 2006-01, Vol.47 (1), p.205-207

2006

Volltextzugriff (PDF)

Lack of clinical benefit of drug-eluting compared to bare-metal stents for treatment of transplant coronary artery disease: Why we do not need drug-eluting stents?

Catheterization and cardiovascular interventions, 2013-08, Vol.82 (2), p.237-237

2013

Volltextzugriff (PDF)

Randomized comparison between bare-metal stent plus colchicine versus drug-eluting stent alone in prevention of clinical adverse events after percutaneous coronary intervention

Future cardiology, 2021-07, Vol.17 (4), p.539-547

2021

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(117)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(43)
Cardiac & Cardiovascular Systems
(34)
Humans
(34)
Cardiovascular System & Cardiology
(30)
Stents
(29)
Male
(23)
Female
(21)
Aged
(18)
Middle Aged
(18)
Treatment Outcome
(17)
Cardiology
(15)
Technology
(14)
Cardiovascular
(13)
Coronary Angiography
(12)
Drug-Eluting Stents
(12)
Heart Attacks
(12)
Coronary Vessels
(11)
Coronary Artery Disease - Therapy
(10)
Sirolimus - Administration & Dosage
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genomic Factors and Therapeutic Approaches in HIV-Associated Neurocognitive Disorders: A Comprehensive Review

Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients

Protein Plasma Levels of the IGF Signalling System Are Altered in Major Depressive Disorder

Therapeutic Approaches in Lysosomal Storage Diseases

Inflammatory and Cardiovascular Biomarkers to Monitor Fabry Disease Progression

Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients

Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two‐year follow‐up of the observational, prospective, controlled, and multicenter ERACI IV registry

Trends in primary percutaneous coronary intervention for the treatment of acute coronary ST-elevation myocardial infarction in Latin American countries: insights from the CECI consortium

Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?

Transapical Implantation of a 2nd-Generation JenaValve Device in Patient with Extremely High Surgical Risk

Association between Peer Victimization (PV) in Childhood/Adolescence and Personality Disorders among Adult Patients

Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): Immediate and long-term results

Changes in the safety paradigm with percutaneous coronary interventions in the modern era:Lessons learned from the ASCERT registry

Five-Year Follow-Up of the Argentine Randomized Trial of Coronary Angioplasty With Stenting Versus Coronary Bypass Surgery in Patients With Multiple Vessel Disease (ERACI II)

Adjudicating Causes of Death in Revascularization Randomized Clinical Trials

Drug-Eluting vs Bare-Metal Stents for Percutaneous Coronary Intervention

Early Assessment of Myocardial Viability by the Use of Delayed Enhancement Computed Tomography After Primary Percutaneous Coronary Intervention

Increased incidence of serious late adverse events with drug-eluting stents when compared with coronary artery bypass surgery: a cause of concern

TCT-644 Use of New Thienopyridines in Patients with Coronary Artery Disease Treated with Percutaneous Coronary Interventions in Argentina. Results From A “Real World” Multicenter Registry

Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease

High Non-Cardiac Death Incidence Should Be a Limitation of Drug-Eluting Stents Implantation? Insights from Recent Randomized Data

Pilot study of oral rapamycin to prevent restenosis in patients undergoing coronary stent therapy: Argentina Single-Center Study (ORAR Trial)

Coronary Stent Thrombosis in the Current Drug-Eluting Stent Era: Insights From the ERACI III Trial

Lack of clinical benefit of drug-eluting compared to bare-metal stents for treatment of transplant coronary artery disease: Why we do not need drug-eluting stents?

Randomized comparison between bare-metal stent plus colchicine versus drug-eluting stent alone in prevention of clinical adverse events after percutaneous coronary intervention

Suchergebnisse filtern